Clients will now have access to a full range of commercialization services on a time-of-need basis supported by a hand-picked team of talented professionals with specific expertise relevant to the disease, approaches to treatment, competitive landscape, evidence generation and dissemination, and value proposition of their new treatment.
Tag Archive for: product commercialization
“Curtis is a former payer who is invaluable to the strategic arm of our business, integral to the high quality of work we deliver, and a voice that our clients and employees respect,” said John Guarino, president and managing partner of Peregrine Market Access. “Promoting Curtis to the highest level of leadership at the company reflects his indispensable role and my confidence in him to help take our company to the next level.”
The KlickRx plugin makes it quick and easy to access physician payment information using generative AI.
Rising to meet the dynamic demands of the healthcare sector, The Bloc Value Builders, a Bloc Agency, has strategically expanded its footprint in market access by introducing a consultancy division. The Value Builders announced this groundbreaking initiative is further strengthened by the appointment of Carolyn Atchison. She will serve as the senior vice president of market access consulting, boasting more than 20 years of expertise at industry front-runners like Amgen and Acadia Pharmaceuticals.
Bringing a drug to market is harder than ever, and manufacturers continue to navigate a complex road to get therapies to patients. On average, manufacturers spend more than $125 million over the three years leading up to launch, yet two-thirds of drugs fail to meet launch expectations.
Med Ad News spoke with Nadia Ward, business development manager at global in vitro diagnostic company bioMérieux, about the company’s role in helping manufacturers produce safe cell and gene therapies.
By integrating technology into medical diagnosis and treatment, medtech companies are paving the way for a healthier future for all – but they have some barriers to overcome first. Many of these startups are operating with lean resources, and the high cost of commercializing new products can be debilitating.